Abstract
Motivation: While high-throughput sequencing (HTS) has been used successfully to discover tumor-specific mutant peptides (neoantigens) from somatic missense mutations, the field currently lacks a method for identifying which gene fusions may generate neoantigens. Results: We demonstrate the application of our gene fusion neoantigen discovery pipeline, called INTEGRATE-Neo, by identifying gene fusions in prostate cancers that may produce neoantigens.
| Original language | English |
|---|---|
| Pages (from-to) | 555-557 |
| Number of pages | 3 |
| Journal | Bioinformatics |
| Volume | 33 |
| Issue number | 4 |
| DOIs | |
| State | Published - Feb 15 2017 |
Fingerprint
Dive into the research topics of 'INTEGRATE-neo: A pipeline for personalized gene fusion neoantigen discovery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver